메뉴 건너뛰기




Volumn 60, Issue 5, 2006, Pages 582-589

A review of the management of patients after percutaneous coronary intervention

Author keywords

Anti coagulation; Chest pain; Complications; Devices; Percutaneous coronary intervention; Platelets; Post procedural management

Indexed keywords

ABCIXIMAB; ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; CONTRAST MEDIUM; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPLERENONE; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; FLECAINIDE; HEPARIN; PACLITAXEL; PROPAFENONE; RAPAMYCIN; SPIRONOLACTONE; TIROFIBAN; WARFARIN;

EID: 33646236105     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1368-5031.2006.00824.x     Document Type: Review
Times cited : (9)

References (72)
  • 1
    • 0027392813 scopus 로고
    • A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction
    • Zijlstra F, de Boer MJ, Hoorntje JC et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993; 328: 680-4.
    • (1993) N Engl J Med , vol.328 , pp. 680-684
    • Zijlstra, F.1    de Boer, M.J.2    Hoorntje, J.C.3
  • 2
    • 0033606918 scopus 로고    scopus 로고
    • Early revascularization in acute myocardial infarction complicated by cardiogenic shock
    • Hochman JS, Sleeper LA, Webb JG et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 1999; 341: 625-34.
    • (1999) N Engl J Med , vol.341 , pp. 625-634
    • Hochman, J.S.1    Sleeper, L.A.2    Webb, J.G.3
  • 3
    • 0027396898 scopus 로고
    • A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction
    • Grines CL, Browne KF, Marco J et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993; 328: 673-9.
    • (1993) N Engl J Med , vol.328 , pp. 673-679
    • Grines, C.L.1    Browne, K.F.2    Marco, J.3
  • 4
    • 0027392814 scopus 로고
    • Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction
    • Gibbons RJ, Holmes DR, Reeder GS et al. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 1993; 328: 685-91.
    • (1993) N Engl J Med , vol.328 , pp. 685-691
    • Gibbons, R.J.1    Holmes, D.R.2    Reeder, G.S.3
  • 5
    • 0030908055 scopus 로고    scopus 로고
    • A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction
    • The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators
    • The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997; 336: 1621-8.
    • (1997) N Engl J Med , vol.336 , pp. 1621-1628
  • 6
    • 0034632721 scopus 로고    scopus 로고
    • Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction
    • Schomig A, Kastrati A, Dirschinger J et al. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. N Engl J Med 2000; 343: 385-91.
    • (2000) N Engl J Med , vol.343 , pp. 385-391
    • Schomig, A.1    Kastrati, A.2    Dirschinger, J.3
  • 7
    • 3543088549 scopus 로고    scopus 로고
    • The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes
    • Bach RG, Cannon CP, Weintraub WS et al. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med 2004; 141: 186-95.
    • (2004) Ann Intern Med , vol.141 , pp. 186-195
    • Bach, R.G.1    Cannon, C.P.2    Weintraub, W.S.3
  • 9
    • 33646243936 scopus 로고    scopus 로고
    • Heart stats British Heart Foundation - 2004
    • Heart stats British Heart Foundation - Available at (accessed on 22 June 2005). Available at
    • Heart stats British Heart Foundation -2004. Available at http://www.bhf.org.uk/news/uploaded/fact_sheet2.pdf (accessed on 22 June 2005).
    • (2004)
  • 10
    • 3242730447 scopus 로고    scopus 로고
    • Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trials
    • Agostoni P, Biodi-Zoccai GG, de Benedictis ML et al. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; systematic overview and meta-analysis of randomized trials. J Am Coll Cardiol 2004; 44: 349-56.
    • (2004) J Am Coll Cardiol , vol.44 , pp. 349-356
    • Agostoni, P.1    Biodi-Zoccai, G.G.2    de Benedictis, M.L.3
  • 11
    • 0026527394 scopus 로고
    • Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures
    • Muller DW, Shamir KJ, Ellis SG et al. Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures. Am J Cardiol 1992; 69: 63-8.
    • (1992) Am J Cardiol , vol.69 , pp. 63-68
    • Muller, D.W.1    Shamir, K.J.2    Ellis, S.G.3
  • 12
    • 4344689765 scopus 로고    scopus 로고
    • Radial artery access for coronary angiography and percutaneous coronary intervention
    • Archbold RA, Robinson NM, Schilling RJ. Radial artery access for coronary angiography and percutaneous coronary intervention. BMJ 2004; 329: 443-6.
    • (2004) BMJ , vol.329 , pp. 443-446
    • Archbold, R.A.1    Robinson, N.M.2    Schilling, R.J.3
  • 13
    • 0025291287 scopus 로고
    • Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older
    • Rich MW, Crecelius CA. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. Arch Intern Med 1990; 150: 1237-42.
    • (1990) Arch Intern Med , vol.150 , pp. 1237-1242
    • Rich, M.W.1    Crecelius, C.A.2
  • 14
    • 0024504484 scopus 로고
    • Cardiovascular and renal toxicity of a nonionic radiocontrast agent after cardiac catheterization
    • Davidson C, Hlatky M, Morris K. Cardiovascular and renal toxicity of a nonionic radiocontrast agent after cardiac catheterization. Ann Intern Med 1989; 110: 119-20.
    • (1989) Ann Intern Med , vol.110 , pp. 119-120
    • Davidson, C.1    Hlatky, M.2    Morris, K.3
  • 15
    • 11144356595 scopus 로고    scopus 로고
    • Effect of N-acetylcysteine for prevention of contrast nephropathy in patients with moderate to severe renal insufficiency: A randomized trial
    • Fung J, Szeto C, Chan W et al. Effect of N-acetylcysteine for prevention of contrast nephropathy in patients with moderate to severe renal insufficiency: A randomized trial. Am J Kidney Dis 2004; 43: 801-8.
    • (2004) Am J Kidney Dis , vol.43 , pp. 801-808
    • Fung, J.1    Szeto, C.2    Chan, W.3
  • 16
    • 18744378254 scopus 로고    scopus 로고
    • A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography
    • Durham JD, Caputo C, Dokko J, Zaharakis T, Pahlavan M. A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography. Kidney Int 2002; 62: 2202-7.
    • (2002) Kidney Int , vol.62 , pp. 2202-2207
    • Durham, J.D.1    Caputo, C.2    Dokko, J.3    Zaharakis, T.4    Pahlavan, M.5
  • 17
    • 10744230466 scopus 로고    scopus 로고
    • Oral acetylcysteine as an adjunct to saline hydration for prevention of contrast-induced nephropathy following coronary angiography
    • Goldenberg I, Schechter M, Matetzki S et al. Oral acetylcysteine as an adjunct to saline hydration for prevention of contrast-induced nephropathy following coronary angiography. Eur Heart J 2004; 25: 212-8.
    • (2004) Eur Heart J , vol.25 , pp. 212-218
    • Goldenberg, I.1    Schechter, M.2    Matetzki, S.3
  • 18
    • 0037120963 scopus 로고    scopus 로고
    • Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure
    • Shyu KG, Cheng JJ, Kuan P. Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol 2002; 40: 1383-8.
    • (2002) J Am Coll Cardiol , vol.40 , pp. 1383-1388
    • Shyu, K.G.1    Cheng, J.J.2    Kuan, P.3
  • 19
    • 0036843034 scopus 로고    scopus 로고
    • Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy
    • Allaqaband S, Tumuluri R, Malik AM et al. Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Catheter Cardiovasc Interv 2002; 57: 279-83.
    • (2002) Catheter Cardiovasc Interv , vol.57 , pp. 279-283
    • Allaqaband, S.1    Tumuluri, R.2    Malik, A.M.3
  • 21
    • 2442590642 scopus 로고    scopus 로고
    • Prevention of contrast-induced nephropathy with sodium bicarbonate: A randomized controlled trial
    • Merten GJ, Burgess WP, Gray LV et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: A randomized controlled trial. JAMA 2004; 291: 2328-34.
    • (2004) JAMA , vol.291 , pp. 2328-2334
    • Merten, G.J.1    Burgess, W.P.2    Gray, L.V.3
  • 23
    • 2242477091 scopus 로고
    • Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIIa receptor in high-risk coronary angioplasty
    • EPIC Investigators
    • EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994; 330: 956-61.
    • (1994) N Engl J Med , vol.330 , pp. 956-961
  • 24
    • 0032508297 scopus 로고    scopus 로고
    • Randomized placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade
    • EPISTENT Investigators
    • EPISTENT Investigators. Randomized placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade. Lancet 1998; 352: 87-92.
    • (1998) Lancet , vol.352 , pp. 87-92
  • 25
    • 0031055038 scopus 로고    scopus 로고
    • Acute profound thrombocytopenia after c7E3 Fab (abciximab) therapy
    • Berkowitz SD, Harrington RA, Rund MM, Tcheng JE. Acute profound thrombocytopenia after c7E3 Fab (abciximab) therapy. Circulation 1997; 95: 809-13.
    • (1997) Circulation , vol.95 , pp. 809-813
    • Berkowitz, S.D.1    Harrington, R.A.2    Rund, M.M.3    Tcheng, J.E.4
  • 26
    • 0035897706 scopus 로고    scopus 로고
    • Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: The ESPRIT trial: A randomized controlled trial
    • ESPRIT Investigators (Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrelin Therapy trial)
    • O'Shea JC, Hafley GE, Greenberg S et al. ESPRIT Investigators (Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrelin Therapy trial). Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatideAin coronary stent intervention: The ESPRIT trial: a randomized controlled trial. JAMA 2001; 285: 2468-73.
    • (2001) JAMA , vol.285 , pp. 2468-2473
    • O'Shea, J.C.1    Hafley, G.E.2    Greenberg, S.3
  • 27
    • 0035927988 scopus 로고    scopus 로고
    • Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization
    • The TARGET Investigators
    • The TARGET Investigators. Comparison of two platelet glycoprotein IIb/ IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. N Engl J Med 2001; 344: 1888-94.
    • (2001) N Engl J Med , vol.344 , pp. 1888-1894
  • 28
    • 0030787769 scopus 로고    scopus 로고
    • ACC/AHA guidelines for exercise testing: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (committee on exercise testing)
    • Gibbons RJ, Balady GJ, Beasley JW et al. ACC/AHA guidelines for exercise testing: ExecAtive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (committee on exercise testing). J Am Coll Cardiol 1997; 30: 260-315.
    • (1997) J Am Coll Cardiol , vol.30 , pp. 260-315
    • Gibbons, R.J.1    Balady, G.J.2    Beasley, J.W.3
  • 29
    • 0024916086 scopus 로고
    • Detection of restenosis after coronary angioplasty for single-vessel disease: How reliable are exercise electrocardiography and scintigraphy in asymptomatic patients?
    • Schroeder E, Marchandise B, De Coster P et al. Detection of restenosis after coronary angioplasty for single-vessel disease: How reliable are exercise electrocardiography and scintigraphy in asymptomatic patients? Eur Heart J 1989; 10 (Suppl. G): 18-21.
    • (1989) Eur Heart J , vol.10 , Issue.SUPPL. G , pp. 18-21
    • Schroeder, E.1    Marchandise, B.2    De Coster, P.3
  • 30
    • 0026545977 scopus 로고
    • Exercise echocardiography versus thallium-201 SPECT for assessing patients before and after PTCA
    • Fioretti PM, Pozzoli MM, Ilmer B et al. Exercise echocardiography versus thallium-201 SPECT for assessing patients before and after PTCA. Eur Heart J 1992; 13: 213-9.
    • (1992) Eur Heart J , vol.13 , pp. 213-219
    • Fioretti, P.M.1    Pozzoli, M.M.2    Ilmer, B.3
  • 31
    • 0025779616 scopus 로고
    • Comparison of usefulness of high-dose dipyridamole echocardiography and exercise electrocardiography for detection of asymptomatic restenosis after angioplasty
    • Pirelli S, Danzi GB, Alberti A et al. Comparison of usefulness of high-dose dipyridamole echocardiography and exercise electrocardiography for detection of asymptomatic restenosis after angioplasty. Am J Cardiol 1991; 67: 1335-8.
    • (1991) Am J Cardiol , vol.67 , pp. 1335-1338
    • Pirelli, S.1    Danzi, G.B.2    Alberti, A.3
  • 32
    • 0001376439 scopus 로고    scopus 로고
    • ACC/AHA guidelines for the clinical application of echocardiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardiography
    • Cheitliun MD, Alpert JS, Armstrong WF et al. ACC/AHA guidelines for the clinical application of echocardiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardiography. Circulation 1997; 71: 1686-744.
    • (1997) Circulation , vol.71 , pp. 1686-1744
    • Cheitliun, M.D.1    Alpert, J.S.2    Armstrong, W.F.3
  • 33
    • 0027404020 scopus 로고
    • Usefulness of supine bicycle stress echocardiography for detection of restenosis after percutaneous transluminal coronary angioplasty
    • Hecht HS, DeBord L, Shaw R et al. Usefulness of supine bicycle stress echocardiography for detection of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1993; 71: 293-6.
    • (1993) Am J Cardiol , vol.71 , pp. 293-296
    • Hecht, H.S.1    DeBord, L.2    Shaw, R.3
  • 34
    • 0028877697 scopus 로고
    • Guidelines for clinical use of cardiac radionuclide imaging: A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular procedures (Committee on radionuclide Imaging) developed in collaboration with the American Society of Nuclear Cardiology
    • Ritchie JL, Bateman TM, Bonow RO et al. Guidelines for clinical use of cardiac radionuclide imaging: A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular procedures (Committee on radionuclide Imaging) developed in collaboration with the American Society of Nuclear Cardiology. J Am Coll Cardiol 1995; 25: 521-47.
    • (1995) J Am Coll Cardiol , vol.25 , pp. 521-547
    • Ritchie, J.L.1    Bateman, T.M.2    Bonow, R.O.3
  • 35
    • 0025777564 scopus 로고
    • Silent ischemia after coronary angioplasty: Evaluation of restenosis and extent of ischemia in asymptomatic patients by tomographic thallium-201 exercise imaging and comparison with symptomatic patients
    • Hecht HS, Shaw RE, Chin HL, Ryan C, Stertzer SH, Myler RK. Silent ischemia after coronary angioplasty: Evaluation of restenosis and extent of ischemia in asymptomatic patients by tomographic thallium-201 exercise imaging and comparison with symptomatic patients. J Am Coll Cardiol 1991; 17: 670-7.
    • (1991) J Am Coll Cardiol , vol.17 , pp. 670-677
    • Hecht, H.S.1    Shaw, R.E.2    Chin, H.L.3    Ryan, C.4    Stertzer, S.H.5    Myler, R.K.6
  • 36
    • 0242551961 scopus 로고    scopus 로고
    • Early exercise after coronary stenting is safe
    • Roffi M, Wenaweser P, Meier B et al. Early exercise after coronary stenting is safe. J Am Coll Cardiol 2003; 42: 1569-73.
    • (2003) J Am Coll Cardiol , vol.42 , pp. 1569-1573
    • Roffi, M.1    Wenaweser, P.2    Meier, B.3
  • 37
    • 0023880273 scopus 로고
    • Sequential thallium-201 myocardial perfusion studies after successful percutaneous transluminal coronary angioplasty: Delayed resolution of exercise-induced scintigraphic abnormalities
    • Manyari D, Knudtson M, Kloiber R. Sequential thallium-201 myocardial perfusion studies after successful percutaneous transluminal coronary angioplasty: Delayed resolution of exercise-induced scintigraphic abnormalities. Circulation 1988; 77: 86-95.
    • (1988) Circulation , vol.77 , pp. 86-95
    • Manyari, D.1    Knudtson, M.2    Kloiber, R.3
  • 38
    • 6944237687 scopus 로고    scopus 로고
    • Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy
    • McFadden EP, Stabile E, Regar E et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 364: 1519-21.
    • (2004) Lancet , vol.364 , pp. 1519-1521
    • McFadden, E.P.1    Stabile, E.2    Regar, E.3
  • 39
    • 0035899289 scopus 로고    scopus 로고
    • Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
    • The Clopidogrel in Unstable Angina to Prevent Recurrent Ischemic Events (CURE) Trial Investigators. [Erratum, N Engl J Med 2001; 345: 1506, 1716]
    • The Clopidogrel in Unstable Angina to Prevent Recurrent Ischemic Events (CURE) Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 345: 494-502 [Erratum, N Engl J Med 2001; 345: 1506, 1716].
    • (2001) N Engl J Med , vol.345 , pp. 494-502
  • 40
    • 0035125034 scopus 로고    scopus 로고
    • Antithrombotic therapy in patients undergoing percutaneous coronary intervention
    • Popma JJ, Ohman EM, Weitz J et al. Antithrombotic therapy in patients undergoing percutaneous coronary intervention. Chest 2001; 119: 321-36S.
    • (2001) Chest , vol.119
    • Popma, J.J.1    Ohman, E.M.2    Weitz, J.3
  • 41
    • 0032542028 scopus 로고    scopus 로고
    • Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: The Multicenter Aspirin and Ticlopidine Trial After Intracoronary Stenting (MATTIS)
    • Urban P, Macaya C, Rupprecht HJ et al. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: The Multicenter Aspirin and Ticlopidine Trial After Intracoronary Stenting (MATTIS). Circulation 1998; 98: 2126-32.
    • (1998) Circulation , vol.98 , pp. 2126-2132
    • Urban, P.1    Macaya, C.2    Rupprecht, H.J.3
  • 42
    • 9244251971 scopus 로고    scopus 로고
    • A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents
    • Schomig A, Neumann FJ, Kastrati A et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996; 334: 1084-9.
    • (1996) N Engl J Med , vol.334 , pp. 1084-1089
    • Schomig, A.1    Neumann, F.J.2    Kastrati, A.3
  • 43
    • 0032481092 scopus 로고    scopus 로고
    • A clinical trial comparing three antithrombotic drug regimens after coronary artery stenting
    • Stent Anticoagulation Restenosis Study Investigators
    • Leon MB, Baim DS, Popma JJ et al. A clinical trial comparing three antithrombotic drug regimens after coronary artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med 1998; 339: 1665-71.
    • (1998) N Engl J Med , vol.339 , pp. 1665-1671
    • Leon, M.B.1    Baim, D.S.2    Popma, J.J.3
  • 44
    • 7844220998 scopus 로고    scopus 로고
    • Randomised multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The Full Anticoagulation versus Aspirin and Ticlopidine (FANTASTIC) Study
    • Bertrand ME, Legrand V, Boland J et al. Randomised multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The Full Anticoagulation versus Aspirin and Ticlopidine (FANTASTIC) Study. Circulation 1998; 98: 1597-603.
    • (1998) Circulation , vol.98 , pp. 1597-1603
    • Bertrand, M.E.1    Legrand, V.2    Boland, J.3
  • 45
    • 0030590746 scopus 로고    scopus 로고
    • A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE)
    • CAPRIE Steering Committee
    • CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet 1996; 348: 1329-39.
    • (1996) Lancet , vol.348 , pp. 1329-1339
  • 46
    • 0033941958 scopus 로고    scopus 로고
    • Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin
    • Bhatt DL, Hirsch AT, Topol EJ et al. Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin. Am Heart J 2000; 140: 67-73.
    • (2000) Am Heart J , vol.140 , pp. 67-73
    • Bhatt, D.L.1    Hirsch, A.T.2    Topol, E.J.3
  • 47
    • 2342435108 scopus 로고    scopus 로고
    • Safety and efficacy of aspirin, clopidogrel and warfarin after coronary stent placement in patients with an indication for anticoagulation
    • Orford JL, Fasseas P, Berger PB et al. Safety and efficacy of aspirin, clopidogrel and warfarin after coronary stent placement in patients with an indication for anticoagulation. Am Heart J 2004; 147: 463-7.
    • (2004) Am Heart J , vol.147 , pp. 463-467
    • Orford, J.L.1    Fasseas, P.2    Berger, P.B.3
  • 48
    • 0034935240 scopus 로고    scopus 로고
    • Long-term clinical outcome after coronary balloon angioplasty: Identification of a population at low risk of recurrent events during 17 years of follow-up
    • Van Domburg RT, Foley DP, de Feyter PJ et al. Long-term clinical outcome after coronary balloon angioplasty: Identification of a population at low risk of recurrent events during 17 years of follow-up. Eur Heart J 2001; 22: 934-41.
    • (2001) Eur Heart J , vol.22 , pp. 934-941
    • Van Domburg, R.T.1    Foley, D.P.2    de Feyter, P.J.3
  • 49
    • 31644447091 scopus 로고    scopus 로고
    • Arterial Revascularization Therapies Study Part II: Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions
    • American College of Cardiology Annual Scientific Session
    • Serruys PW. Arterial Revascularization Therapies Study Part II: Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions. American College of Cardiology 2005 Annual Scientific Session.
    • (2005)
    • Serruys, P.W.1
  • 50
    • 0035849152 scopus 로고    scopus 로고
    • Comparison of coronary artery bypass surgery and stenting for the treatment of multivessel disease
    • Serruys PW, Unger F, Sousa JE et al. Comparison of coronary artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001; 344: 1117-97.
    • (2001) N Engl J Med , vol.344 , pp. 1117-1124
    • Serruys, P.W.1    Unger, F.2    Sousa, J.E.3
  • 51
    • 0031543303 scopus 로고    scopus 로고
    • Primary prevention of sudden cardiac death in heart failure: Will the solution be shocking?
    • Uretsky BF, Sheahan RG. Primary prevention of sudden cardiac death in heart failure: Will the solution be shocking? J Am Coll Cardiol 1997; 30: 1589-97.
    • (1997) J Am Coll Cardiol , vol.30 , pp. 1589-1597
    • Uretsky, B.F.1    Sheahan, R.G.2
  • 52
    • 0026785561 scopus 로고
    • Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
    • The SOLVD Investigators. [Erratum appears in N Engl J Med 1992; 327: 1768]
    • The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327: 685-91. [Erratum appears in N Engl J Med 1992; 327: 1768].
    • (1992) N Engl J Med , vol.327 , pp. 685-691
  • 53
    • 0029937949 scopus 로고    scopus 로고
    • The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
    • U S Carvedilol Heart Failure Study Group
    • Packer M, Bristow MR, Cohn JN et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U S Carvedilol Heart Failure Study Group. N Engl J Med 1996; 334: 1349-55.
    • (1996) N Engl J Med , vol.334 , pp. 1349-1355
    • Packer, M.1    Bristow, M.R.2    Cohn, J.N.3
  • 54
    • 0033514046 scopus 로고    scopus 로고
    • The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomized trial
    • CIBIS-II Investigators
    • CIBIS-II Investigators. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomized trial. Lancet 1999; 353: 9-13.
    • (1999) Lancet , vol.353 , pp. 9-13
  • 55
    • 0033549290 scopus 로고    scopus 로고
    • Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial Congestive Heart Failure (MERIT-HF)
    • MERIT-HF Study Group
    • MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial Congestive Heart Failure (MERIT-HF). Lancet 1999; 353: 2001-7.
    • (1999) Lancet , vol.353 , pp. 2001-2007
  • 56
    • 0024321898 scopus 로고
    • Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction
    • The Cardiac Arrhythmia Suppression Trial (CAST) Investigators
    • The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 321: 406-12.
    • (1989) N Engl J Med , vol.321 , pp. 406-412
  • 57
    • 0033840161 scopus 로고    scopus 로고
    • Randomised comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest
    • The Cardiac Arrest Study Hamburg (CASH)
    • Kuck KH, Cappato R, Siebels J et al. Randomised comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest. The Cardiac Arrest Study Hamburg (CASH). Circulation 2000; 102: 748-54.
    • (2000) Circulation , vol.102 , pp. 748-754
    • Kuck, K.H.1    Cappato, R.2    Siebels, J.3
  • 58
    • 19944429413 scopus 로고    scopus 로고
    • Amiodarone or an implantable cardioverter defibrillator for congestive heart failure
    • SCD-HeFT Investigators
    • Brady GH, Lee KL, Mark DB et al. SCD-HeFT Investigators. Amiodarone or an implantable cardioverter defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-37.
    • (2005) N Engl J Med , vol.352 , pp. 225-237
    • Brady, G.H.1    Lee, K.L.2    Mark, D.B.3
  • 59
    • 0034688194 scopus 로고    scopus 로고
    • Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
    • The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators
    • Yusuf S, Sleight P, Pogue J et al. The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 145-53.
    • (2000) N Engl J Med , vol.342 , pp. 145-153
    • Yusuf, S.1    Sleight, P.2    Pogue, J.3
  • 60
    • 0042330455 scopus 로고    scopus 로고
    • Efficacy of perindopril in the prevention of cardiovascular events among patients with stable coronary artery disease: Randomized, double-blind, placebo-controlled, multicentre trial (the EUROPA study)
    • The European Trial On Reduction of Cardiac Events with Perindopril in Stable Coronary Artery Disease Investigators
    • The European Trial On Reduction of Cardiac Events with Perindopril in Stable Coronary Artery Disease Investigators. Efficacy of perindopril in the prevention of cardiovascular events among patients with stable coronary artery disease: Randomized, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003; 362: 782-8.
    • (2003) Lancet , vol.362 , pp. 782-788
  • 61
    • 0041909380 scopus 로고    scopus 로고
    • Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: The CHARM-Alternative trial
    • The CHARM Investigators
    • Granger C, McMurray J, Yusuf S et al. The CHARM Investigators. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: The CHARM-Alternative trial. Lancet 2003; 362: 772-6.
    • (2003) Lancet , vol.362 , pp. 772-776
    • Granger, C.1    McMurray, J.2    Yusuf, S.3
  • 62
    • 0041408235 scopus 로고    scopus 로고
    • Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: The CHARM-Added trial
    • The CHARM Investigators
    • McMurray J, Ostergren J, Swedberg K et al. The CHARM Investigators. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: The CHARM-Added trial. Lancet 2003; 362: 767-71.
    • (2003) Lancet , vol.362 , pp. 767-771
    • McMurray, J.1    Ostergren, J.2    Swedberg, K.3
  • 63
    • 0033517302 scopus 로고    scopus 로고
    • Randomised Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
    • Pitt B, Zannad F, Remme W et al. Randomised Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341: 709-17.
    • (1999) N Engl J Med , vol.341 , pp. 709-717
    • Pitt, B.1    Zannad, F.2    Remme, W.3
  • 64
    • 0037417252 scopus 로고    scopus 로고
    • Eplerenone Post-acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
    • Pitt B, Remme W, Zannad F et al. Eplerenone Post-acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348: 1309-21.
    • (2003) N Engl J Med , vol.348 , pp. 1309-1321
    • Pitt, B.1    Remme, W.2    Zannad, F.3
  • 65
    • 9844224486 scopus 로고    scopus 로고
    • A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias
    • The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators
    • The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576-83.
    • (1997) N Engl J Med , vol.337 , pp. 1576-1583
  • 66
    • 0034696531 scopus 로고    scopus 로고
    • Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone
    • Connolly SJ, Gent M, Roberts RS et al. Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000; 101: 1297-302.
    • (2000) Circulation , vol.101 , pp. 1297-1302
    • Connolly, S.J.1    Gent, M.2    Roberts, R.S.3
  • 67
    • 0006918490 scopus 로고    scopus 로고
    • Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia
    • Moss AJ, Hall WJ, Cannon DS et al. Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 335: 1933-40.
    • (1996) N Engl J Med , vol.335 , pp. 1933-1940
    • Moss, A.J.1    Hall, W.J.2    Cannon, D.S.3
  • 68
    • 0037149716 scopus 로고    scopus 로고
    • Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction
    • Multicenter Automatic Defibrillator Implantation Trial Investigators
    • Moss AJ, Zareba W, Hall WJ et al. Multicenter Automatic Defibrillator Implantation Trial Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-83.
    • (2002) N Engl J Med , vol.346 , pp. 877-883
    • Moss, A.J.1    Zareba, W.2    Hall, W.J.3
  • 69
    • 20044374193 scopus 로고    scopus 로고
    • A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging
    • Yu CM, Zhang Q, Fung JW et al. A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging. J Am Coll Cardiol 2005; 45: 677-84.
    • (2005) J Am Coll Cardiol , vol.45 , pp. 677-684
    • Yu, C.M.1    Zhang, Q.2    Fung, J.W.3
  • 70
    • 0037071808 scopus 로고    scopus 로고
    • Cardiac resynchronization in chronic heart failure
    • Abraham WT, Fisher WG, Smith AL et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346: 1845-53.
    • (2002) N Engl J Med , vol.346 , pp. 1845-1853
    • Abraham, W.T.1    Fisher, W.G.2    Smith, A.L.3
  • 71
    • 16844364826 scopus 로고    scopus 로고
    • The effect of cardiac resynchronization on morbidity and mortality in heart failure
    • The Cardiac Resynchronization - Heart Failure (CARE-HF) Study Investigators
    • Cleland JG, Daubert JC, Erdmann E et al. The Cardiac Resynchronization - Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 325: 1539-49.
    • (2005) N Engl J Med , vol.325 , pp. 1539-1549
    • Cleland, J.G.1    Daubert, J.C.2    Erdmann, E.3
  • 72
    • 2442479695 scopus 로고    scopus 로고
    • Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
    • Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators
    • Bristow MR, Saxon LA, Boehmer J et al. Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-50.
    • (2004) N Engl J Med , vol.350 , pp. 2140-2150
    • Bristow, M.R.1    Saxon, L.A.2    Boehmer, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.